ConductScience.org, home

Paper41459511

Conceptual quantitative systems pharmacology framework for supporting clinical trial design in organ-specific autoimmune and rare diseases.

Sun Z and 2 others. Front Immunol, 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Conceptual quantitative systems pharmacology framework for supporting clinical trial design in organ-specific autoimmune and rare diseases. Papers, record 41459511. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41459511

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Conceptual quantitative systems pharmacology framework for supporting clinical trial design in organ-specific autoimmune and rare diseases.
PubMed
Journal
Front Immunol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2025-12-31
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sun ZZhengwu
2Xi YYalin
3Lan XXiaoyan

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Rare DiseasesMajor topic
Autoimmune DiseasesMajor topic
Clinical Trials as TopicMajor topic
Humans
Research Design
Bayes Theorem
Systems Biology
Organ Specificity
Computer Simulation
Drug Development

Source PubMed

Download CSV of topics

References63

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135352835Relationship Between Anifrolumab Pharmacokinetics, Pharmacodynamics, and Efficacy in Patients With Moderate to Severe Systemic Lupus Erythematosus.J Clin Pharmacol2022https://conductscience.org/library/papers/35352835PubMed
235260419Endopeptidase Cleavage of Anti-Glomerular Basement Membrane Antibodies in vivo in Severe Kidney Disease: An Open-Label Phase 2a Study.J Am Soc Nephrol2022https://conductscience.org/library/papers/35260419PubMed
326212387Human autoimmune diseases: a comprehensive update.J Intern Med2015https://conductscience.org/library/papers/26212387PubMed
436001711Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis.N Engl J Med2022https://conductscience.org/library/papers/36001711PubMed
531161268Translational Quantitative Systems Pharmacology in Drug Development: from Current Landscape to Good Practices.AAPS J2019https://conductscience.org/library/papers/31161268PubMed
625502178A modified murine model of systemic sclerosis: bleomycin given by pump infusion induced skin and pulmonary inflammation and fibrosis.Lab Invest2015https://conductscience.org/library/papers/25502178PubMed
737898164Physiological Indirect Response Model to Omics-Powered Quantitative Systems Pharmacology Model.J Pharm Sci2024https://conductscience.org/library/papers/37898164PubMed
832620589Ultra-rare disease: an European perspective.Eur Respir Rev2020https://conductscience.org/library/papers/32620589PubMed
937146963Virtual patients, digital twins and causal disease models: Paving the ground for in silico clinical trials.Drug Discov Today2023https://conductscience.org/library/papers/37146963PubMed
1030667172Best Practices to Maximize the Use and Reuse of Quantitative and Systems Pharmacology Models: Recommendations From the United Kingdom Quantitative and Systems Pharmacology Network.CPT Pharmacometrics Syst Pharmacol2019https://conductscience.org/library/papers/30667172PubMed
1137809085A quantitative systems pharmacology model for certolizumab pegol treatment in moderate-to-severe psoriasis.Front Immunol2023https://conductscience.org/library/papers/37809085PubMed
1239632463Quantitative Systems Pharmacology-Based Digital Twins Approach Supplements Clinical Trial Data for Enzyme Replacement Therapies in Pompe Disease.Clin Pharmacol Ther2025https://conductscience.org/library/papers/39632463PubMed
1339771538The Role of Pharmacometrics in Advancing the Therapies for Autoimmune Diseases.Pharmaceutics2024https://conductscience.org/library/papers/39771538PubMed
1430123942Population Pharmacokinetics of the Interleukin-23 Inhibitor Risankizumab in Subjects with Psoriasis and Crohn's Disease: Analyses of Phase I and II Trials.Clin Pharmacokinet2019https://conductscience.org/library/papers/30123942PubMed
1539062600Preparing for Patient-Customized N-of-1 Antisense Oligonucleotide Therapy to Treat Rare Diseases.Genes (Basel)2024https://conductscience.org/library/papers/39062600PubMed
1630697975Reproducibility of Quantitative Systems Pharmacology Models: Current Challenges and Future Opportunities.CPT Pharmacometrics Syst Pharmacol2019https://conductscience.org/library/papers/30697975PubMed
1727761201The promises of quantitative systems pharmacology modelling for drug development.Comput Struct Biotechnol J2016https://conductscience.org/library/papers/27761201PubMed
1837984065Creating a Roadmap to Quantitative Systems Pharmacology-Informed Rare Disease Drug Development: A Workshop Report.Clin Pharmacol Ther2024https://conductscience.org/library/papers/37984065PubMed
1931529677A Quantitative Systems Pharmacology Consortium Approach to Managing Immunogenicity of Therapeutic Proteins.CPT Pharmacometrics Syst Pharmacol2019https://conductscience.org/library/papers/31529677PubMed
2040743487Long-Term Efficacy and Safety of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder From the SAkuraMoon Open-Label Extension Study.Neurol Neuroimmunol Neuroinflamm2025https://conductscience.org/library/papers/40743487PubMed

See all 63 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn PapersSource
42812715Anti-CD19 CAR T-cell therapy for autoimmune diseases: from exploratory clinical trials to quantitative pharmacodynamic modeling development.Front Immunol2026https://conductscience.org/library/papers/42812715PubMed
42080091Neural-immune-cancer crosstalk in pancreatic cancer: mechanisms and clinical translation.Front Cell Dev Biol2026https://conductscience.org/library/papers/42080091PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41459511

GET https://conductscience.org/api/papers/v1/41459511/references?page=2